Cao Pharmaceuticals Inc. Email Format
Pharmaceutical ManufacturingTexas, United States2-10 Employees
Cao Pharmaceuticals Inc. is a small, early-stage oncology drug developer within the pharmaceutical manufacturing sector. The company seeks to create cancer therapies that combine strong efficacy with low and manageable toxicity, with development timelines intended to be shorter than those of traditional chemotherapy. Its focus is on advancing its lead drug to address multiple cancer indications while prioritizing patient safety and potential clinical benefit. Headquartered in Webster, Texas, the organization operates with a compact team and a targeted development program. At the time of the provided information, Cao Pharmaceuticals was conducting a Phase I trial of its lead drug, with Phase II trials previously scheduled for Q3 2017.